Copoly.ai

Detect Cancer Earlier Blood-Based Multi-Cancer Early Detection Empowering clinicians and patients with AI-driven biomarker analysis for earlier, more accurate cancer detection Discover OncoSage AI-Powered Productivity Enterprise AI Assistant for Modern Teams Streamlining workflows and accelerating decision-making for government agencies and enterprise organizations Explore OfficeSage Strategic AI Consulting Transform Your Business with Intelligent AI Strategy Helping organizations assess AI readiness, design adoption roadmaps, and build competitive advantage through AI Start a Conversation Bioinformatics Expertise Advanced Computational Biology and Multi-Omics Solutions Accelerating research and discovery with custom bioinformatics pipelines, multi-omics analysis, and AI-driven insights Explore Our Services Slider1 Slider1

Pioneering AI Solutions for Health and Business

Who We Are

Copoly is a Canadian biopharma AI company on a mission to make life-saving technology accessible and intelligent. We build products and services that sit at the intersection of artificial intelligence, clinical science, and enterprise productivity — helping healthcare providers detect cancer earlier, organizations work smarter, and research teams move faster.

From our flagship cancer detection platform to enterprise AI tools and deep bioinformatics consulting, everything we do is driven by one belief: that AI should solve real problems for real people.

Advancing Health and Business Through AI

Our Offerings
  • OncoSage

    A blood-based multi-cancer early detection platform powered by advanced biomarker analysis and machine learning. Built for clinicians, hospitals, and researchers who need accurate, timely results when it matters most.

  • OfficeSage

    An enterprise AI productivity assistant built for government agencies and large organizations. Streamlines workflows, accelerates decision-making, and integrates securely within your existing infrastructure.

  • Consultation Hub

    Strategic consulting across AI adoption and computational biology. From AI readiness assessments and implementation roadmaps to multi-omics pipelines and bioinformatics analysis — tailored to your organization's needs.

Detect Cancer Earlier with OncoSage

Blood-Based Cancer Detection

OncoSage is Copoly’s flagship multi-cancer early detection platform. Using advanced biomarker analysis and machine learning, it identifies cancer signals from a single blood draw — giving clinicians and patients a critical head start in the fight against cancer.

Designed for hospitals, diagnostic labs, and research institutions who need accuracy, speed, and clinical credibility in one platform.

Work Smarter with OfficeSage

Enterprise AI Productivity

OfficeSage is Copoly’s enterprise AI assistant — built from the ground up for the demands of government agencies, large enterprises, and operations teams who need secure, reliable, and intelligent productivity tools.

From document analysis and workflow automation to decision support and knowledge management — OfficeSage brings the power of AI into your daily operations without compromising security or compliance.

Trusted by Researchers, Clinicians and Government

Recognition & Impact

40+

Happy Clients

120+

Combined Years of Expertise

12+

Active Engagements

85+

Successful Deliverables

Latest News and Insights

From Our Blog
CRISPR gene editing

Unlocking the Future of Cancer Therapy: CRISPR/Cas Meets Copoly

The field of biomedical research is on the cusp of a transformative era, driven by the convergence of artificial intelligence (AI) and genomics. At the forefront of this revolution is…

Copoly.ai Awarded Second Place at BioNext MedTech Innovation Challenge

London, ON – March 2025 – wwwdev.copoly.ai/, a leader in AI-powered cancer diagnostics, is proud to announce that it has been awarded second place at the BioNext MedTech Innovation Challenge…
DNA circos plot

EVO-2: Revolutionizing Biomedical Research with AI-Driven Genomics

The field of biomedical research is on the cusp of a transformative era, driven by the convergence of artificial intelligence (AI) and genomics. At the forefront of this revolution is…

Preparing for AI in Genetic Engineering R&D: A Roadmap for Success

Artificial Intelligence (AI) is transforming industries at an unprecedented pace, and genetic engineering is no exception. With AI’s potential to accelerate research, optimize workflows, and unlock insights from complex datasets,…

Beyond Off-the-Shelf: How Custom AI Ensures Security and Competitive Edge 

In the race to adopt AI technologies, many businesses eagerly embrace public large language models (LLMs) like ChatGPT. While these tools offer impressive capabilities, they also introduce significant risks that…

Case Study: Automating Semiconductor Testing and Packaging with AI-Powered Solutions

Case study – key highlights Discover how a leading semiconductor manufacturer partnered with wwwdev.copoly.ai/ to revolutionize their testing and packaging processes. By implementing our custom AI-powered system, the company was…